Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
D000244:Adenosine Diphosphate / Q000031:analogs & derivatives* / Q000097:blood / Q000138:chemical synthesis / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors; D000262:Adenylyl Cyclases / Q000097:blood; D000527:Alprostadil; D001386:Azides / Q000097:blood / Q000138:chemical synthesis / Q000494:pharmacology; D001665:Binding Sites; D001792:Blood Platelets / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D000242:Cyclic AMP / Q000097:blood; D006801:Humans; D007700:Kinetics; D010761:Phosphorus Radioisotopes; D010974:Platelet Aggregation / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology; D013056:Spectrophotometry, Ultraviolet
D000067956:Adenylyl Cyclase Inhibitors; D001386:Azides; D010761:Phosphorus Radioisotopes; D011458:Prostaglandins E; D000244:Adenosine Diphosphate; C022295:2-azidoadenosine 3',5'-diphosphate; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D000527:Alprostadil